Enjoy 10% Off All Products! Proudly Made in USA. Shop Now!

Enjoy 10% Off All Products! Proudly Made in USA. Shop Now!

Enjoy 10% Off All Products! Proudly Made in USA. Shop Now!

Respiratory Syncytial Virus Efficacy Model

RSV infection is responsible for a significant number of respiratory diseases in infants and morbidity in elderly populations. The cotton rat (S. hispidus) is susceptible to non-adapted human RSV.

Animals are infected by intranasal inoculation with RSV-A2. This is a non-lethal model that has been used to successfully test RSV vaccine and therapeutic candidates leading to IND and clinical development. Model kinetics indicate peak viral burden at day 4 or 5 post challenge followed by recovery through day7.
The best indicator of efficacy is viral load at the peak of infection and lung viremia is an indicator of morbidity.

KEY FEATURES

Description: Lung viremia data (plaque assay) collected from
cotton rats challenged with 1x LD90 of Respiratory syncytial virus
(A2) via the intranasal (IN) route.

Description: Lung viremia data (plaque assay) collected from
cotton rats challenged with 1x LD90 of Respiratory syncytial virus
(A2) via the intranasal (IN) route.

Strain

  • RSV-A A2
  • RSV-A Long
  • RSV-A 9320
  • RSV-A 18537
  • RSV-B WV 14617-85

Testing Available

  • Cotton Rat Efficacy, Viral Neutralization Assays
  • Viral Neutralization Assays
  • Viral Neutralization Assays
  • Viral Neutralization Assays
  • Viral Neutralization Assays

Sign up for our newsletter
Linkedin Instagram Youtube

Copyright © 2023. All rights reserved by Stratedgy.

Contact Us

For Product Information,
Orders & Technical Support

products@integratedbiotherapeutics.com

For Services
services@ibtbioservices.com

Company

Media

Services By Disease Target

Search
Generic filters